BNP Paribas Financial Markets’s Harmony Biosciences HRMY Stock Holding History

BNP Paribas Financial Markets’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16M	Sell	438,302 -106,886	-20%	-$3.37M	0.01%	1354
2026 Q1	$15.3M	Buy	545,188 +20,043	+4%	+$657K	0.01%	1324
2025 Q4	$19.7M	Buy	525,145 +130,001	+33%	+$4.27M	0.01%	1195
2025 Q3	$10.9M	Buy	395,144 +87,979	+29%	+$3.03M	0.01%	1487
2025 Q2	$9.71M	Buy	307,165 +267,658	+677%	+$8.61M	0.01%	1465
2025 Q1	$1.31M	Sell	39,507 -19,350	-33%	-$694K	﹤0.01%	2591
2024 Q4	$2.03M	Buy	+58,857	New	+$2.02M	﹤0.01%	2354
2022 Q4	–	Sell	-44,836	Closed	-$1.99M	–	4291
2022 Q3	$1.99M	Buy	+44,836	New	+$2.19M	﹤0.01%	1962

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BNP Paribas Financial Markets's HRMY Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Harmony Biosciences (HRMY) stake by 20% in Q2 2026, selling an estimated $3.37M and leaving 438,302 shares worth $16M. The position accounts for 0.01% of the portfolio, ranked #1354.

BNP Paribas Financial Markets first reported a position in HRMY in Q3 2022 and has held it in 8 quarters since. The position peaked at $19.7M in Q4 2025. 272 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

BNP Paribas Financial Markets held 438,302 shares of Harmony Biosciences worth $16M as of Q2 2026.
BNP Paribas Financial Markets sold 106,886 Harmony Biosciences shares in Q2 2026, an estimated $3.37M.
Harmony Biosciences made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1354 holding.
BNP Paribas Financial Markets first reported a position in Harmony Biosciences in Q3 2022 and has held it in 8 quarters since.
BNP Paribas Financial Markets's Harmony Biosciences position peaked at $19.7M in Q4 2025.
272 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.